GLP-3 (R)
GLP-3 (R)
Price range: $ 53 through $ 257
A triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Considered a next-generation obesity drug. The glucagon component boosts energy expenditure and liver fat metabolism, while GLP-1 and GIP reduce appetite and improve insulin action.
Benefits
✓ Exceptional weight loss (up to 24%+ in Phase 2 trials)
✓ Rapid fat reduction including visceral fat
✓ Improved metabolic markers (glucose, lipids, liver enzymes)
✓ Increased energy expenditure via glucagon pathway
✓ Promising MASH/fatty liver treatment
✓ Rapid fat reduction including visceral fat
✓ Improved metabolic markers (glucose, lipids, liver enzymes)
✓ Increased energy expenditure via glucagon pathway
✓ Promising MASH/fatty liver treatment
Side Effects
• Nausea and vomiting
• Injection site reactions
• Decreased appetite (can be excessive)
• Headache
• Mild hypoglycemia risk
• Injection site reactions
• Decreased appetite (can be excessive)
• Headache
• Mild hypoglycemia risk
Half Life
7 days
Note
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. Composition and dosing ratios are vendor-defined and not independently verified.
GLP-3 (R)
Price range: $ 53 through $ 257
A triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Considered a next-generation obesity drug. The glucagon component boosts energy expenditure and liver fat metabolism, while GLP-1 and GIP reduce appetite and improve insulin action.
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. Composition and dosing ratios are vendor-defined and not independently verified.
✓ Exceptional weight loss (up to 24%+ in Phase 2 trials)
✓ Rapid fat reduction including visceral fat
✓ Improved metabolic markers (glucose, lipids, liver enzymes)
✓ Increased energy expenditure via glucagon pathway
✓ Promising MASH/fatty liver treatment
✓ Rapid fat reduction including visceral fat
✓ Improved metabolic markers (glucose, lipids, liver enzymes)
✓ Increased energy expenditure via glucagon pathway
✓ Promising MASH/fatty liver treatment
7 days
